Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer - long-term follow-up of the SPCG-6 study.
Frederik B Thomsen, Klaus Brasso, Ib J Christensen, Jan-Erik Johansson, Anders Angelsen, Teuvo L J Tammela, Peter Iversen, Scandinavian Prostate Cancer Group
18Citationer
(Scopus)
Fingeraftryk
Dyk ned i forskningsemnerne om 'Survival benefit of early androgen receptor inhibitor therapy in locally advanced prostate cancer - long-term follow-up of the SPCG-6 study.'. Sammen danner de et unikt fingeraftryk.